1-11 of 11
Galina Salogub
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Atherosclerosis Risk Factors in Chronic Myeloid Leukemia Patients Under Durable Tyrosine Kinase Inhibitors Therapy

Nadezhda Shnalieva, Iurii Osipov, Darina Zammoeva, Pavel Kabanov, Oxana Rotar, Maria Boyarinova, Marina Dyshluk, Galina Salogub, Elena Vasilieva, Elza Lomaia
Journal: Blood
Blood (2024) 144 (Supplement 1): 6617.
https://doi.org/10.1182/blood-2024-211387
Published: 2024
Journal Articles

Long-Term Outcomes in Blastic Phase Chronic Myeloid Leukemia - One Center Experience

Darina Zammoeva, Yulia Alexeeva, Dmitry Motorin, Ekaterina Ovsyannikova, Olga Kulemina, Renat Badaev, Nadezhda Shnalieva, Vladimir Ivanov, Galina Salogub, Aleksina Shatilova, Larisa Girshova, Nadiya Siordiya, Irina Budaeva, Elza Lomaia
Journal: Blood
Blood (2024) 144 (Supplement 1): 6616.
https://doi.org/10.1182/blood-2024-211328
Published: 2024
Journal Articles

Long-Term Outcomes from the Phase 3 OCEAN (OP-103) Study: Melflufen and Dexamethasone (Dex) Versus Pomalidomide (Pom) and Dex in Relapsed Refractory Multiple Myeloma (RRMM)

Fredrik Schjesvold, Meletios A. Dimopoulos, Sosana Delimpasi, Pawel Robak, Daniel Coriu, Wojciech Maciej Legiec, Ludek Pour, Ivan Spicka, Tamas Masszi, Vadim Anatolievich Doronin, Jiri Minarik, Galina Salogub, Yulia Alexeeva, Antonio Lazzaro, Vladimir Maisnar, Gabor Mikala, Stefan Norin, Marcus Thuresson, Anna Bergan, Jakob Obermüller, Roman Hajek, Maria-Victoria Mateos, Paul G. Richardson, Pieter Sonneveld
Journal: Blood
Blood (2023) 142 (Supplement 1): 2018.
https://doi.org/10.1182/blood-2023-177945
Published: 2023
Journal Articles

Clinical Outcomes in Patients (Pts) with Dose Reduction of Selinexor in Combination with Bortezomib, and Dexamethasone (XVd) in Previously Treated Multiple Myeloma from the Boston Study

Sundar Jagannath, Thierry Facon, Ashraf Z. Badros, Moshe Levy, Philippe Moreau, Sosana Delimpasi, Maryana Simonova, Ivan Spicka, Iryna Kriachok, Maria Gavriatopoulou, Halyna Pylypenko, Holger W Auner, Xavier Leleu, Vadim Doronin, Ganna Usenko, Roman Hajek, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Chris P. Venner, Mamta Garg, Mercedes Gironella Mesa, Artur Jurczyszyn, Tadeusz Robak, Monica Galli, Craig Thomas Wallington-Beddoe, Atanas Radinoff, Galina Salogub, Don Stevens, Supratik Basu, Anna Marina Liberati, Hang Quach, Veselina S Goranova Marinova, Jelena Sreten Bila, Eirini Katodritou, Andrew DeCastro, Yi Chai, Dane R. Van Domelen, Moran Mishal, Ohad S. Bentur, Jatin Shah, Sharon Shacham, Michael G. Kauffman, Sebastian Grosicki, Paul G. Richardson
Journal: Blood
Blood (2021) 138 (Supplement 1): 3793.
https://doi.org/10.1182/blood-2021-146003
Published: 2021
Journal Articles

A Phase 1 Study Investigating AFM11 in Patients with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: Preliminary Results

Galina Salogub, MD PhD, Jiri Mayer, MD, Frantisek Folber, MD PhD, Sebastian Grosicki, MD PhD, Aleksander B Skotnicki, MD PhD, Anna Prochwicz, MD, Alexander Myasnikov, MD, Alexander Gural, MD, Oliver Schoenborn-Kellenberger, MSc, Charlie Brindley, PhD, Stefan Knackmuss, PhD, Sylvia Schwarz, PhD, Sandra Schmich, Cassandra Choe-Juliak, MD MS, Andras Strassz, MD, Leila Alland, MD, Michael Doubek, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3969.
https://doi.org/10.1182/blood-2018-99-118136
Published: 2018
Journal Articles

The Impact of Genetic Abnormalities (GA) and Other Factors on Survival in Patients after 65 Years with Multiple Myeloma (MM)

Andrei Garifullin, Irina Martynkevich, MD PhD, Sergei Voloshin, Alexei Kuvshinov, Ludmila Martynenko, Elizaveta Kleina, Galina Salogub, Elena Karyagina, Alexander Schmidt, Kudrat Abdulkadyrov
Journal: Blood
Blood (2015) 126 (23): 5314.
https://doi.org/10.1182/blood.V126.23.5314.5314
Published: 2015
Journal Articles

The Results of the Russian Registry of Primary Immune Thrombocytopenia (ITP) in Adults

Igor Lisukov, MD, PhD, Alexey Maschan, Prof, Anastasia Shamardina, MD, Tatyana Chagorova, MD, Igor Davydkin, Prof., Tatyana Sycheva, MD, Tamara Zagoskina, MD, Elena Karyagina, MD, Galina Salogub, MD, Marina Savinova, MD, Tatyana Schelekhova, MD, Lidiya Kovaleva, Prof, Tatyana Schneider, MD, Anna Unzhekova, MD, Elena Kuznetsova, MD, Yuriy Schatochin, Prof, Maria Ivanova, MD, Elena Vinogradova, MD, Kamil Kaplanov, MD, Inna Markova, MD, Olimpiada Kanjukova, MD, Kudrat Abdulkadyrov, MD, Julia Sedlova, MD, Svetlana Osynikhina, MD, Nina Tsvetaeva, MD, Elena Volodicheva, MD, Aryslan Akhmadeev, MD, Michael A Maschan, MD PhD, Alexandr Kulagin, MD, PhD, Alexander Rumyantsev, Prof, Boris V Afanasyev, Professor
Journal: Blood
Blood (2015) 126 (23): 4642.
https://doi.org/10.1182/blood.V126.23.4642.4642
Published: 2015
Journal Articles

Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients

Annika Dufour, Giuseppe Palermo, Evelyn Zellmeier, Gudrun Mellert, Guillemette Duchateau-Nguyen, Stephanie Schneider, Tobias Benthaus, Purvi M. Kakadia, Karsten Spiekermann, Wolfgang Hiddemann, Jan Braess, Sim Truong, Nancy Patten, Lin Wu, Sabine Lohmann, David Dornan, Debraj GuhaThakurta, Ru-Fang Yeh, Galina Salogub, Philippe Solal-Celigny, Anna Dmoszynska, Tadeusz Robak, Marco Montillo, John Catalano, Christian H. Geisler, Martin Weisser, Stefan K. Bohlander
Journal: Blood
Blood (2013) 121 (18): 3650–3657.
https://doi.org/10.1182/blood-2012-10-458695
Published: 2013
Includes: Supplemental data
Journal Articles

Disruption of TP53 function by Point Mutations and Deletions Is Associated with An Increased Risk of Disease Progression within Previously Treated, Relapsed Chronic Lymphocytic Leukemia Patients

Annika Dufour, Stefan K Bohlander, Evelyn Zellmeier, Gudrun Mellert, Karsten Spiekermann, MD, Stephanie Schneider, PhD, Purvi Kakadia, Wolfgang Hiddemann, PhD, Jan Braess, Sim Truong, Nancy Patten, Lin Wu, Galina Salogub, Philippe Solal-Celigny, Anna Dmoszynska, Tadeusz Robak, Boris V Afanasiev, Marco Montillo, John Catalano, MBBS FRACP FRCPA, Christian H. Geisler, David Dornan, Ming Lin, Ru-Fang Yeh, Martin Weisser, Guillemette Duchateau-Nguyen, Giuseppe Palermo
Journal: Blood
Blood (2011) 118 (21): 2445.
https://doi.org/10.1182/blood.V118.21.2445.2445
Published: 2011
Journal Articles

Low Expression of MiR-34a in Previously Treated Chronic Lymphocytic Leukemia Patients Is Limited to Patients with a Complete Disruption of TP53 Function and Does Not Correlate with MDM2 SNP309,

Annika Dufour, PhD, Stefan K Bohlander, Evelyn Zellmeier, Gudrun Mellert, Karsten Spiekermann, MD, Stephanie Schneider, PhD, Purvi Kakadia, Wolfgang Hiddemann, PhD, Jan Braess, Sim Truong, Nancy Patten, Lin Wu, Galina Salogub, Philippe Solal-Celigny, Anna Dmoszynska, Tadeusz Robak, Boris V Afanasiev, Marco Montillo, John Catalano, MBBS FRACP FRCPA, Christian H. Geisler, David Dornan, Ming Lin, Ru-Fang Yeh, Martin Weisser, Guillemette Duchateau-Nguyen, Giuseppe Palermo
Journal: Blood
Blood (2011) 118 (21): 3521.
https://doi.org/10.1182/blood.V118.21.3521.3521
Published: 2011
Journal Articles

Early Response (ER) Is a Prognostic Marker for PFS in CLL Treated by Fludarabine Containing Regimens.

Elena Stadnik, Galina Salogub, Yulia Alekseeva, Natalija Lazorko, Eugene Nikitin, Andrey Zaritskey
Journal: Blood
Blood (2009) 114 (22): 2377.
https://doi.org/10.1182/blood.V114.22.2377.2377
Published: 2009